O

OrbiMed Portfolio holdings

AUM $4.59B
1-Year Est. Return 131.45%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+131.45%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.17B
AUM Growth
+$193M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
120
New
Increased
Reduced
Closed

Top Buys

1
+$52.4M
2
+$48.2M
3
+$38.6M
4
ASND icon
Ascendis Pharma A/S
ASND
+$29.4M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$28.9M

Top Sells

1
+$105M
2
+$93.6M
3
+$81.8M
4
BSX icon
Boston Scientific
BSX
+$39.8M
5
CYTK icon
Cytokinetics
CYTK
+$35.6M

Sector Composition

1 Healthcare 99.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
76
$6.84M 0.16%
+901,500
77
$6.44M 0.15%
+3,221,828
78
$5.85M 0.14%
3,322,488
79
$5.14M 0.12%
2,133,405
80
$4.65M 0.11%
790,901
-131,058
81
$4.58M 0.11%
531,163
82
$4.46M 0.11%
2,252,987
83
$4.34M 0.1%
+367,824
84
$4.15M 0.1%
+84,020
85
$3.98M 0.1%
466,601
-253,300
86
$3.09M 0.07%
378,556
+83,609
87
$1.94M 0.05%
13,459
88
$1.84M 0.04%
+347,000
89
$1.55M 0.04%
32,400
90
$1.22M 0.03%
588,800
91
$1.12M 0.03%
605,531
92
$1M 0.02%
250,000
93
$840K 0.02%
51,727
94
$752K 0.02%
192,700
95
$655K 0.02%
80,420
96
$474K 0.01%
59,046
-243,719
97
$358K 0.01%
76,600
98
– –
-3,099,265
99
– –
-5,779,071
100
– –
-54,799
1 2 3
4
5